NCT00019890
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +12 more
- Locations
-
Not specified
Clinical trial condition
Recurrent Melanoma
Explore clinical trials studying Recurrent Melanoma. Study availability and eligibility vary by location and protocol.
83 public trials
2 recruiting studies
Recurrent Melanoma trial results
Completed
Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors
NCT01709435
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +30 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Children's Hospital of Orange County Orange, California, United States
- UCSF Medical Center-Parnassus San Francisco, California, United States
- UCSF Medical Center-Mission Bay San Francisco, California, United States
NCT02304458
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +53 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Children's Hospital Los Angeles Los Angeles, California, United States
- Children's Hospital of Orange County Orange, California, United States
- Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
Completed
Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma
NCT01359956
- Conditions
- Malignant Melanoma, Melanoma, Neoplasms, +11 more
- Locations
-
Not specified
Completed
Evaluating SINE KPT-330 in Treating Patients With Melanoma That Cannot Be Removed By Surgery
NCT02120222
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
- Locations
-
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States
NCT02013492
- Conditions
- Adenocarcinoma, Adnexal Diseases, Breast Diseases, +42 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT02296112
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +13 more
- Locations
-
- Georgetown University Medical Center Washington D.C., District of Columbia, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
- M D Anderson Cancer Center Houston, Texas, United States
Completed
Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer
NCT01037790
- Conditions
- Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Adult Central Nervous System Germ Cell Tumor, +74 more
- Locations
-
- Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT01328535
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT01886235
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +19 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States